Compare COCP & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COCP | SMSI |
|---|---|---|
| Founded | 2006 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1M | 14.0M |
| IPO Year | 2011 | 2017 |
| Metric | COCP | SMSI |
|---|---|---|
| Price | $1.07 | $2.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 44.4K | 22.0K |
| Earning Date | 05-15-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 54.65 | ★ 62.94 |
| EPS | N/A | ★ N/A |
| Revenue | $12,712,091.00 | ★ $17,363,000.00 |
| Revenue This Year | N/A | $13.97 |
| Revenue Next Year | N/A | $53.35 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.76 | $0.41 |
| 52 Week High | $2.03 | $6.13 |
| Indicator | COCP | SMSI |
|---|---|---|
| Relative Strength Index (RSI) | 58.44 | 58.96 |
| Support Level | $0.99 | $2.66 |
| Resistance Level | $1.11 | $6.13 |
| Average True Range (ATR) | 0.06 | 0.15 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 93.14 | 72.43 |
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
Smith Micro Software Inc provides software solutions that simplify and enhance the mobile experience to some of the wireless service providers around the globe. The company's solutions include SafePath product suite provides comprehensive and easy-to-use tools to protect family digital lifestyles and manage connected devices both inside and outside the home; CommSuite premium messaging platform helps mobile service providers deliver a next-generation voicemail experience to mobile subscribers, while monetizing a legacy cost-center; and ViewSpot its retail display management platform provided wireless carriers and retailers with a way to bring powerful on-screen, interactive demos to life. It operates in single segment: Wireless.